Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
about
Genetic Models for the Study of Luteinizing Hormone Receptor FunctionSynergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumorsInfertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient miceActivation of the lutropin/choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2).Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excessTransgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralizationLuteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice.Animal models for aberrations of gonadotropin action.Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targetsLutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse.The mammalian ovary from genesis to revelation.TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
P2860
Q26781559-1522E316-4E39-41C7-9644-B20093DA9112Q27324860-CE11736B-177C-4AA5-BFA8-67630254194AQ30357869-6AD7C2F4-35E5-49AA-A6F7-0728F63FFD91Q30437941-0BA37933-9228-425B-839E-53BA0299FAC5Q30446457-C6081754-2993-49F4-B1F2-96E7E030A9C4Q33775566-11F1A064-4907-45B6-81E5-0E1F1458E7C6Q34506308-95235D26-794E-42A0-A0DA-8B6429E21044Q35033055-D32A3267-430E-463E-98C7-264F0037FD72Q35523514-6B1C31CF-FE13-42D3-841E-3EC63195EBDCQ35853333-97CAABCF-6200-4886-A398-6FC2BABB8ED8Q36158251-0AC99F36-F67E-46C8-A9E3-B2E5D6DD725FQ36421441-29221440-F272-4C13-AC40-5A43883ED2D5Q37385514-824EA737-C872-4A11-9E13-B5ABEE27372CQ38949348-570AEEBE-D03E-49A2-8DF9-70211461753CQ39972260-8F28DF06-59D2-4D6C-9E95-EA5348DBEB8FQ46437623-4B2AC1B7-4017-476E-8A5F-0B4A46BC22A4
P2860
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@ast
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@en
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@nl
type
label
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@ast
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@en
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@nl
prefLabel
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@ast
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@en
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@nl
P2093
P1476
Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
@en
P2093
Ilpo Huhtaniemi
Matti Poutanen
Petteri Ahtiainen
Susana Rulli
P304
P356
10.1016/J.MCE.2004.10.013
P577
2005-04-01T00:00:00Z